---
layout: post
title: "Patient-Focused Drug Development: Workshop #2 To Discuss Methodologic and Other Challenges Related to Patient Experience Data; Public Workshop; Request for Comments"
date: 2026-02-04 21:49:11 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-16514
original_published: 2025-08-28 00:00:00 +0000
significance: 8.00
---

# Patient-Focused Drug Development: Workshop #2 To Discuss Methodologic and Other Challenges Related to Patient Experience Data; Public Workshop; Request for Comments

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** August 28, 2025 00:00 UTC
**Document Number:** 2025-16514

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Patient-Focused Drug Development: Workshop #2 to Discuss Methodologic and Other Challenges Related to Patient Experience Data." The purpose of the public workshop is to discuss methodological challenges related to patient experience data, and other areas of greatest interest or concern to public stakeholders.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/08/28/2025-16514/patient-focused-drug-development-workshop-2-to-discuss-methodologic-and-other-challenges-related-to)
- API: https://www.federalregister.gov/api/v1/documents/2025-16514

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
